European Pain Federation (EFIC) Position Paper on: Appropriate Opioid Use in Chronic Pain Management

Size: px
Start display at page:

Download "European Pain Federation (EFIC) Position Paper on: Appropriate Opioid Use in Chronic Pain Management"

Transcription

1 European Pain Federation (EFIC) Position Paper on: Appropriate Opioid Use in Chronic Pain Management 2017 Structured Cooperation between Health Care Systems tackling the societal impact of pain! Prof Tony O Brien Marymount University Hospital & Hospice Cork University Hospital College of Medicine & Health, University College Cork, Ireland Malta June 2017

2 Disclosure Statement of conflict of interest in the context of the subject of this presentation Within the past 12 months, I have had following financial interest/arrangement(s) or affiliation(s) below. Support for travel Honoraria for lectures Honoraria for advisory board activities Participation in clinical trials Research funding Financial shares and options.. Mundipharma Mundipharma Nil Nil Nil Nil

3 Appropriate Opioid Use in Chronic Pain Management Poorly controlled pain is a global public health issue Pain management is inadequate across most of the world (Declaration of Montreal, IASP) Personal, familial, societal costs are immeasurable Opioids are highly effective and safe analgesics only when used appropriately by competent clinicians The misuse of opioids is very dangerous Achieving a Balance (UN Single Convention on Narcotics, 1961 & World Health Organisation, 2011) O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

4 INCB data on opioid consumption ( ) 92% of the world's morphine is consumed by 17% of the world's population Consumption in defined daily doses for statistical purposes (S-DDD) per million inhabitants per day

5 Pain relief lottery

6 Opioid analgesics ensuring adequate access for medical and scientific purposes INCB, 2016 Lack of training & awareness amongst healthcare professionals Fear of addiction Fear of diversion Cultural attitudes Limited financial resources INCB / United Nations, New York

7 Negative Perceptions The negative perception about controlled drugs among medical professionals and patients in many countries has limited their rational use 1 Opioid phobia rooted in physician and patient attitudes driven by fear of addiction and misuse Lack of balanced debate and broad understanding of the benefit-risk ratio of opioids Impacts access and use of opioids (even if regulatory provisions are made); and in consequence contributes to undertreatment of pain The International Narcotics Control Board (INCB) Annual Report, Press Release No.6. Use of essential narcotic drugs to treat pain is inadequate, especially in developing countries. March Available at:

8 Silent epidemic of pain Uncomplaining patients & unquestioning doctors - a lethal conspiracy of silence -

9 Appropriate Opioid Use in Chronic Pain Management Opioids are indispensable for the management of pain Opioids are not a panacea for all painful conditions Opioids are not used in isolation, but as part of a multi- faceted strategy that includes: Adjuvant analgesics Non-drug interventions Psychological support Rehabilitation Opioids must be readily accessible under supervision for those who legitimately require such therapy O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

10 Opioid misconceptions Dangerous Compromise function Shorten life / hasten death Tolerance Addiction Respiratory depression Confusion / disorientation End of life only Opioids kill pain by killing patient If a patient dies whilst on opioid medication, the opioid caused the death O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

11

12 Appropriate Opioid Use in Chronic Pain Management O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

13 The Pendulum Swings for Opioid Prescribing Physicians and the public share a common belief that opioids, even if prescribed by a physician for a medical indication, cause addiction The belief that prescribed opioid drugs cause addiction is flawed We must understand how the data are generated Illustration 1: Divide the number of opioid addicts who first started on prescription drugs (numerator) by the total number of opioid addicts (denominator) = a large number!! But, this is the wrong methodology Illustration 2: Divide all of the people in pain who are treated with an opioid and who become addicted (numerator) by the total number of pain patients treated with an opioid (denominator) = % - a very small number Is it better to let patients suffer unnecessarily than to be falsely implicated in contributing to a rise in addiction and opioid related deaths? Charles F von Gunten. (ed) Journal of Palliative Medicine Vol 19, Number 4,

14 Opioid facts - for medical use in properly selected and supervised patients Indispensable in pain management No significant respiratory depression Safe & effective Bowel dysfunction is main concern Do not compromise function Inter-individual variation in response Introduce when less potent medicines are ineffective No single ideal opioid; therefore need a range of opioids Physical dependence is not addiction Opioid misuse causes harm; not opioid use O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

15 Medical use of opioids Adequate patient assessment Close on-going patient supervision Clinicians familiar with best practice Treatment initiated on trial basis Non-specialists need access to expert advice Patient & family education on safe opioid use and storage Opioids prescribed by competent doctors Opioids dispensed by competent pharmacists Correct dose is lowest possible dose Honest doctor / patient relationship O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

16 Appropriate Opioid Use in Chronic Pain Management Summary / Conclusions Pain is a global public health problem In Europe: Lack of understanding of the nature and impact of chronic pain Failure to routinely assess patients for pain Failure to apply basic fundamental principles of prescribing in respect of opioids Inappropriate and exaggerated fear concerning the legitimate scientific use of opioids in carefully selected and supervised patients In selected countries, overly stringent and ill-considered restrictions and regulations intended to prevent illicit, non-medical use of opioids, result in patients suffering unnecessarily Opioids should only be introduced when less potent analgesics and adjuvant therapies have failed to achieve and maintain adequate pain relief and rehabilitation A positive educational programme targeted at health care professionals / students and the general public is urgently required O Brien T, Christrup LL, Drewes AM et al. European Pain Federation Position Paper. Eur J Pain 21 (2017) 3-19

17

18 The medical profession is compassionate enough and bright enough to learn how to prescribe opioids when they are indicated, in ways that maximise benefit and minimise risk...we owe it to our patients to ensure access to comprehensive pain management, including the medically appropriate use of opioids Alford DP. New Engl J Med, 2016

19 European Pain Federation position paper on appropriate opioid use in chronic pain management T O Brien (Chairperson) L L Christrup A M Drewes M T Fallon H G Kress H J McQuay G Mikus B J Morlion J Perez-Cajaraville E Pogatzki -Zahn G Varrassi J C D Wells Eur J Pain 21 (2017) 3-19

International drug control conventions promote better health

International drug control conventions promote better health International drug control conventions promote better health The preamble of both 1961 and 1971 Conventions refer to their scope and impact on health: The parties, Concerned with the health and welfare

More information

Improving analgesic use to support pain management at the end of life

Improving analgesic use to support pain management at the end of life Improving analgesic use to support pain management at the end of life March 2017 British Medical Association bma.org.uk British Medical Association Improving analgesic use to support pain management at

More information

Revised Appendix E of the Code of Professional Conduct promulgated in Issue No. 24 of the newsletter of the Medical Council in December 2017

Revised Appendix E of the Code of Professional Conduct promulgated in Issue No. 24 of the newsletter of the Medical Council in December 2017 Revised Appendix E of the Code of Professional Conduct promulgated in Issue No. 24 of the newsletter of the Medical Council in December 2017 A. Application of Guidelines Guidelines on Proper Prescription

More information

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and

3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and 3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and combating hepatitis, 3.4 Prevention and treatment of

More information

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol 18 October 2016 International Drug Control Conventions Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol Convention on Psychotropic Substances of 1971 United Nations Convention

More information

C. Impediments to the availability of narcotic drugs

C. Impediments to the availability of narcotic drugs 28 AVAILABILITY OF INTERNATIONALLY CONTROLLED DRUGS C. Impediments to the availability of narcotic drugs Figure 31. Availability of narcotic drugs, as evaluated by countries themselves, 2014 107. In 2014,

More information

Gilberto Gerra. Drug Prevention and Health Branch

Gilberto Gerra. Drug Prevention and Health Branch Operational Recommendations on ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes, while preventing their diversion Gilberto Gerra Drug Prevention

More information

Alberta WCB Policies & Information

Alberta WCB Policies & Information 1. What are the objectives of WCB regarding the authorization of prescribed opioid analgesics As part of an overall approach to effective, appropriate claims management, including the provision of and

More information

Within the Scope of Practice/Role of _X APRN RN LPN CNA ADVISORY OPINION PAIN MANAGEMENT GUIDELIINES

Within the Scope of Practice/Role of _X APRN RN LPN CNA ADVISORY OPINION PAIN MANAGEMENT GUIDELIINES Wyoming State Board of Nursing 130 Hobbs Avenue, Suite B Cheyenne, WY 82002 Phone (307) 777-7601 Fax (307) 777-3519 E-Mail: wsbn-info-licensing@wyo.gov Home Page: https://nursing-online.state.wy.us/ OPINION:

More information

UNODC/HONLAF/26/CRP.1

UNODC/HONLAF/26/CRP.1 8 September 2016 English only Twenty-sixth Meeting of the Heads of National Drug Law Enforcement Agencies, Africa Addis Ababa, 19-23 September 2016 Item 5 (c) of the provisional agenda * Best practices

More information

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults BACKGROUND The justification for developing these guidelines lies

More information

Access to pain therapy in the UN resolutions: worldwide perspective

Access to pain therapy in the UN resolutions: worldwide perspective Access to pain therapy in the UN resolutions: worldwide perspective Elizabeth Mattfeld Drug Prevention and Health Branch The Single Convention recognizes the medical use of narcotic drugs as indispensable

More information

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Questionnaire for National Competent Authorities on the availability of Internationally Controlled Substances for medical and scientific purposes

Questionnaire for National Competent Authorities on the availability of Internationally Controlled Substances for medical and scientific purposes Annex. Questionnaire sent in 2014 to competent national authorities of Member States on the availability of internationally controlled substances for medical and scientific purposes Questionnaire for National

More information

WHO/EDM/QSM/ ENGLISH ONLY DISTRIBUTION: GENERAL WORLD HEALTH ORGANIZATION

WHO/EDM/QSM/ ENGLISH ONLY DISTRIBUTION: GENERAL WORLD HEALTH ORGANIZATION WHO/EDM/QSM/2000.4 ENGLISH ONLY DISTRIBUTION: GENERAL NARCOTIC & PSYCHOTROPIC DRUGS ACHIEVING BALANCE IN NATIONAL OPIOIDS CONTROL POLICY GUIDELINES FOR ASSESSMENT WORLD HEALTH ORGANIZATION World Health

More information

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998 KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble

More information

Pearls in Chronic Pain Management ROBERT HAUPTMAN MD PAIN CONSULTANT HEALTHPOINTE CLINIC ASSISTANT CLINICAL PROFESSOR U OF A

Pearls in Chronic Pain Management ROBERT HAUPTMAN MD PAIN CONSULTANT HEALTHPOINTE CLINIC ASSISTANT CLINICAL PROFESSOR U OF A Pearls in Chronic Pain Management ROBERT HAUPTMAN MD PAIN CONSULTANT HEALTHPOINTE CLINIC ASSISTANT CLINICAL PROFESSOR U OF A Faculty / Presenter Disclosure! Faculty: Robert Hauptman MD! Pain Consultant

More information

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE 41.1 GENERAL PRINCIPLES The ICD 10 diagnostic criteria for dependency syndrome are listed in Table 41.1 below.

More information

Colorado State Board of Medical Examiners Policy

Colorado State Board of Medical Examiners Policy POLICY NUMBER: 10-14 Title: Guidelines for the Use of Controlled Substances for the Treatment of Pain Date Issued: May 16, 1996 Date(s) Revised: November 18, 2004 Reference: 12-36-117, C.R.S. Purpose:

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

PAIN MANAGEMENT. Understanding End-of-Life Pain Management. De Anna Looper, RN CHPN. Carrefour Associates. Management Company for Crossroads Hospice

PAIN MANAGEMENT. Understanding End-of-Life Pain Management. De Anna Looper, RN CHPN. Carrefour Associates. Management Company for Crossroads Hospice Understanding End-of-Life Pain Management De Anna Looper, RN CHPN Carrefour Associates Management Company for Crossroads Hospice August 2009 The effect of uncontrolled pain at the end of life is substantial.

More information

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment

More information

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 Prepared by: Adam Osprey Policy & Development Pharmacist adam.osprey@cps.scot Who

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer European Pain Federation (EFIC) position paper on appropriate opioid use in chronic pain management Citation for published version: O'Brien, T, Christrup, L, Drewes, AM, Fallon,

More information

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Safe Prescribing of Drugs with Potential for Misuse/Diversion College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines

More information

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Vermont. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of

More information

European Legal Database on Drugs

European Legal Database on Drugs European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative

More information

Opioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older

Opioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older Opioid Prescribing for Acute Pain Care for People 15 Years of Age and Older Summary This quality standard provides guidance on the appropriate prescribing, monitoring, and tapering of opioids to treat

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS Background information Substance misusers who develop palliative care needs are likely to have psychological, social and existential

More information

Challenges in Access to controlled medicines

Challenges in Access to controlled medicines Challenges in Access to controlled medicines Strengthening Pharmaceutical Systems for better access Vienna, UNODC 27 September 2017 Name of Author Function Division Country www.who.int Agenda Global landscape

More information

The Parents Back to School Kit Part 2 Kids and the misuse of Medications

The Parents Back to School Kit Part 2 Kids and the misuse of Medications The Parents Back to School Kit Part 2 Kids and the misuse of Medications Prescription drugs and over the counter medications are the third most commonly misused substances (after alcohol and cannabis)

More information

TITLE SECOND LINE SPEAKER

TITLE SECOND LINE SPEAKER WENNBERG INTERNATIONAL COLLABORATIVE SPRING POLICY MEETING 2018 Inter-regional Variation In Opioid Prescription Patterns In Emilia-romagna And Tuscany TITLE STYLE MARIA PIA FANTINI, DARIO TEDESCO, BRUNA

More information

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership

More information

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic Preventing Controlled Substance Diversion David B. Brushwood, R.Ph.,., J.D. Professor of Pharmaceutical Outcomes & Policy The University of Florida Teaching Objectives Describe the balance a that must

More information

Is opioid over-regulation hurting cancer patients?

Is opioid over-regulation hurting cancer patients? ents? For reprint orders, please contact: reprints@futuremedicine.com Is opioid over-regulation hurting cancer patients? While opioids are not the only medication used for the treatment of cancer pain,

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

Safe Medication Practices

Safe Medication Practices Safe medication practices for life. Slide 1 Safe Medication Practices Facilitator Talking Points Welcome to today s program, Generation Rx: Safe Medication Practices for Life. You may be asking yourself,

More information

MQAC Rules for the Management of Chronic Non-Cancer Pain For Allopathic Physicians Effective January 2, 2012

MQAC Rules for the Management of Chronic Non-Cancer Pain For Allopathic Physicians Effective January 2, 2012 MQAC Rules for the Management of Chronic Non-Cancer Pain For Allopathic Physicians Effective January 2, 2012 WAC 246-919-850 Pain management Intent. These rules govern the use of opioids in the treatment

More information

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July 2018 Title of Report: Status: Board Sponsor: Author: Appendices Gosport Hospital Report & RUH Assurance For Information Dr

More information

California. Prescribing and Dispensing Profile. Research current through November 2015.

California. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2377/18 25 April 2018 Original: Español MEASURES TO

More information

Myths Related to the treatment of pain.

Myths Related to the treatment of pain. Good Evening. Myths Related to the treatment of pain. My goal this evening is to give you an opportunity to understand some of the strongly held beliefs concerning pain treatment which have been shared

More information

Overview of Pain Types and Prevalence

Overview of Pain Types and Prevalence Pain Resource Nurse Overview of Pain Types and Prevalence Pain Resource Nurse Program Module 1 The Resource Center of the Alliance of State Pain Initiatives University of Wisconsin Board of Regents, 2011

More information

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services To: Health and justice commissioners and providers Public Health England health and justice leads Her Majesty s Prison and Probation Service Home Office immigration removal centre leads Health and justice

More information

OICS INCB. Statement by Dr. Viroj Sumyai, President, International Narcotics Control Board (INCB)

OICS INCB. Statement by Dr. Viroj Sumyai, President, International Narcotics Control Board (INCB) UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD INCB OICS Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria Telephone: +43-1-26060, Telefax: +43-1-26060-5867 / 5868 E-Mail: incb.secretariat@un.org

More information

Strategies for Federal Agencies

Strategies for Federal Agencies Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid

More information

The Difficult Patient: Risk Mitigation Strategies

The Difficult Patient: Risk Mitigation Strategies The Difficult Patient: Risk Mitigation Strategies C. Scott Anthony, D.O. Pain Management of Tulsa 1 Opioid Backlash National emergency Opioids not indicated for chronic pain Forces pushing for reduction

More information

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subsection: Analgesics and Opioids Original Policy Date: May 8, 2015 Subject: Meperidine Page: 1 of 5 Last

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

CSS Perspective - Opioid Risk Management

CSS Perspective - Opioid Risk Management Tufts Health Care Institute Program on Opioid Risk Management Risk Evaluation and Mitigation Strategy for Prescription Opioids: An In-Depth Review of Fundamental Issues CSS Perspective - Opioid Risk Management

More information

HPNA Position Statement Pain Management

HPNA Position Statement Pain Management HPNA Position Statement Pain Management Background Pain is a common symptom in most serious or life-threatening illnesses. Pain is defined as an unpleasant subjective sensory and emotional experience associated

More information

Information & statistics related to alcohol & drug misuse and community pharmacybased brief advice & intervention

Information & statistics related to alcohol & drug misuse and community pharmacybased brief advice & intervention Information & statistics related to alcohol & drug misuse and community pharmacybased brief advice & intervention 1 INTRODUCTION Alcohol and Drug Misuse and their related harms cost our society hundreds

More information

Readopt with amendment Med 502, effective (Document #11090), to read as follows:

Readopt with amendment Med 502, effective (Document #11090), to read as follows: Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing

More information

LISTENING SUB-TEST QUESTION PAPER

LISTENING SUB-TEST QUESTION PAPER Sample Test 2 LISTENING SU-TEST QUESTION PPER NDIDTE NUMER: LST NME: FIRST NME: OTHER NMES: PROFESSION: VENUE: TEST DTE: Your details and photo will be printed here. Passport Photo NDIDTE SIGNTURE: TIME:

More information

Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain

Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Management Centre; Centre for Addiction and Mental Health Toronto,

More information

National Council on Patient Information and Education

National Council on Patient Information and Education National Council on Patient Information and Education You are not alone The type of pain that caused your doctor to prescribe a pain medicine for you can make you feel that you are different from everyone

More information

Palliative care for children with Rare Diseases

Palliative care for children with Rare Diseases Palliative care for children with Rare Diseases Busi Nkosi International Children s Palliative Care Network Need for children s palliative care More than 21 million children need palliative care worldwide

More information

OICS INCB. Vienna, 7 November Fostering a united approach to the effective implementation of the three international drug control conventions

OICS INCB. Vienna, 7 November Fostering a united approach to the effective implementation of the three international drug control conventions UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD INCB OICS NATIONS UNIES ORGANE INTERNATIONAL DE CONTRÔLE DES STUPÉFIANTS Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria Telephone:

More information

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond David Anisman, MD Medical Director, Farmington Health Center (Primary Care) Associate Medical Director, Community

More information

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Education Program for Prescribers and Pharmacists

Education Program for Prescribers and Pharmacists Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under this Program Abstral (fentanyl)

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID

More information

Changing Prescribing Practices In Dentistry

Changing Prescribing Practices In Dentistry Changing Prescribing Practices In Dentistry Paul J. Desjardins, D.M.D., Ph.D. Adjunct Clinical Professor, Rutgers School of Dental Medicine Visiting Professor, Tufts University, School of Dental Medicine

More information

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. FDA-2012-N-0548 To Whom It May Concern: The American Dental Association

More information

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Preamble This Standard establishes the standards of practice and ethical requirements of all physicians

More information

Launch of the INCB Annual Reports 2015

Launch of the INCB Annual Reports 2015 Launch of the INCB Annual Reports 2015 Werner Sipp, INCB President 2 March 2016 1 The 3 Reports 2 Mandate of INCB Promote and monitor compliance with the 3 international drug control conventions by: Annual

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

To Prescribe or Not To Prescribe

To Prescribe or Not To Prescribe To Prescribe or Not To Prescribe AzSHRM Quarterly Meeting May 11, 2018 Presented by: Karen Wright, RN BSN ARM CPHRM MICA Senior Risk Management Consultant 1 OBJECTIVES List three common classes of medications

More information

Foundations of Safe and Effective Pain Management

Foundations of Safe and Effective Pain Management Foundations of Safe and Effective Pain Management Evidence-based Education for Nurses, 2018 Module 1: The Multi-dimensional Nature of Pain Module 2: Pain Assessment and Documentation Module 3: Management

More information

Drug misuse and dependence: UK guidelines on clinical management review proposal

Drug misuse and dependence: UK guidelines on clinical management review proposal Drug misuse and dependence: UK guidelines on clinical management review proposal Adfam submission September 2014 Introduction Adfam welcomes this chance to offer feedback on the orange book clinical guidelines.

More information

GP Cluster Network Action Plan Upper Valleys Cluster

GP Cluster Network Action Plan Upper Valleys Cluster GP Cluster Network Action Plan 2015-16 Upper Valleys Cluster The Cluster Network 1 Development Domain supports GP Practices to work to collaborate to: Understand local health needs and priorities. Develop

More information

Using strong opiods for pain in palliative care

Using strong opiods for pain in palliative care Using strong opiods for pain in palliative care What are strong opioids? They are strong medicines used to control pain when weaker painkillers have not been effective. (They can also sometimes be used

More information

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5

NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5 NHS...... Grampian Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults Co-ordinators: Consultant Anaesthetist, Lead Acute Pain

More information

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple

More information

Ketamine. Expert peer review on critical review report (1) 35 th Expert Committee on Drug Dependence, Hammamet, Tunisia June 4-8, 2012

Ketamine. Expert peer review on critical review report (1) 35 th Expert Committee on Drug Dependence, Hammamet, Tunisia June 4-8, 2012 Ketamine Expert peer review on critical review report (1) 35 th Expert Committee on Drug Dependence, Hammamet, Tunisia June 4-8, 2012 1. Comments based on the review report a. Evidence on dependence and

More information

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014

There are no financial or other pertinent conflicts of interest to disclose. Learning Objectives: Key Questions To Ask 10/4/2014 Maintaining Patient Safety When Chronic Opioid Therapy Is Prescribed P. David Pacheco, Ph.C, PA-C, CAAAPM Pain Medication Management Specialist Southwest Interventional Pain Specialists, PC 4700 Jefferson

More information

The opioid regulatory paradox

The opioid regulatory paradox The international collaborative project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and Middle East: Final Data Nathan I Cherny

More information

Guideline scope Persistent pain: assessment and management

Guideline scope Persistent pain: assessment and management National Institute for Health and Clinical Excellence [document type for example, IFP, QRG] on [topic] Document cover sheet Date Version number Editor 30/08/2017 1 NGC Action 1 2 3 4 5 6 7 8 9 10 11 12

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

TEEN EDUCATION. Medication Safety for Teens.

TEEN EDUCATION. Medication Safety for Teens. Slide 1 Welcome to today s program, My Generation Rx: Medication Safety for Teens. You may be asking yourself, What is My Generation Rx? My Generation Rx encourages teens to incorporate the Generation

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

REAL TIME MONITORING OF PRESCRIPTION MEDICINES BEING A HEALTHY STATE

REAL TIME MONITORING OF PRESCRIPTION MEDICINES BEING A HEALTHY STATE BEING A HEALTHY STATE 2036 WILL MARK OUR STATE S BICENTENARY By the time our State turns 200 years old, I want South Australia to be a place of prosperity. Planning and delivering on my vision for a better

More information

Opioid Management of Chronic (Non- Cancer) Pain

Opioid Management of Chronic (Non- Cancer) Pain Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are

More information

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology

More information

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Frederick A. Curro D.M.D., Ph.D. Director, PEARL Practice Based Research Network Director, Regulatory Affairs, Bluestone

More information

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy POLICY DOCUMENT Document Title Reference Number PRESCRIBING FOR PAIN MANAGEMENT IN OPIOID DEPENDENT CLIENTS CG/pain management in opioid dependency/03/15 Policy Type Clinical Guideline Electronic File/Location

More information

PUBLIC BRIEFING ON THE APM S POSITION ON ASSISTED SUICIDE

PUBLIC BRIEFING ON THE APM S POSITION ON ASSISTED SUICIDE PUBLIC BRIEFING ON THE APM S POSITION ON ASSISTED SUICIDE The Association for Palliative Medicine represents over a 1000 specialist doctors in the UK working in hospices and the NHS. We remain overwhelmingly

More information

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D. Running Head: MEDICATION-ASSISTED TREATMENT ATTITUDES Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program Caroline Allison Dr. Kathleen Moore, Ph.D. Department of Mental Health Law

More information

PRESCRIBING OPIATES IN CONTEXT OF OPIATE USE DISORDER

PRESCRIBING OPIATES IN CONTEXT OF OPIATE USE DISORDER PRESCRIBING OPIATES IN CONTEXT OF OPIATE USE DISORDER Ken Hopper, MD, MBA Health Strategies and Population Health TCU/UNTHSC School of Medicine The Hopper Group-Fort Worth, Arlington, Dallas MAKING IT

More information

Dudley End of Life and Palliative Care Strategy Implementation Plan 2017

Dudley End of Life and Palliative Care Strategy Implementation Plan 2017 Dudley End of Life and Palliative Care Strategy Implementation Plan 2017 End of Life and Palliative Care Strategy 2017 1 Contents Page What is a strategy plan? 3 Terminology 3 Demographics 3 Definitions

More information

WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS

WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS WS2 EVIDENCE IN PAIN THERAPY FROM A SOCIETAL PERSPECTIVE PAIN UNDERTREATMENT IN ONCOLOGICAL PATIENTS CERP CENTER FOR THE RESEARCH & EVALUATION OF CANCER Giovanni Apolone BACKGROUND PAIN AFFLICTS MOST OF

More information

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Case Id: d79bf7da-998d-4fa4-b202-bac606c39a58 Date: 29/04/2016 09:21:26 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please

More information

Australian and New Zealand College of Anaesthetists (ANZCA) Submission to Misuse of Drugs (Medicinal Cannabis) Amendment Bill Page 0

Australian and New Zealand College of Anaesthetists (ANZCA) Submission to Misuse of Drugs (Medicinal Cannabis) Amendment Bill Page 0 Page 0 Table of contents Page 1. Executive Summary 2 2. About ANZCA 3 3. About FPM 4 4. ANZCA response to the Misuse of Drugs (Medicinal Cannabis) Amendment Bill 5 4.1 ANZCA Position on medicinal cannabis

More information